Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's disease. Our patented rapid cognitive analysis technology aims to make early detection a reality, and aims to bring the benefits of being: easier to administer, more accessible, less expensive, allowing earlier and more accurate diagnosis.

Company went into administration in March 2025.